Loading…

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

Saved in:

Bibliographic Details
Published in:	Leukemia 2021-07, Vol.35 (7), p.2108-2113
Main Authors:	Morschhauser, Franck, Dyer, Martin J. S., Walter, Harriet S., Danilov, Alexey V., Ysebaert, Loic, Hodson, Daniel James, Fegan, Christopher, Rule, Simon A., Radford, John, Cartron, Guillaume, Bouabdallah, Krimo, Davies, Andrew John, Spurgeon, Stephen, Rajakumaraswamy, Nishanthan, Li, Biao, Humeniuk, Rita, Huang, Xi, Bhargava, Pankaj, Jürgensmeier, Juliane M., Salles, Gilles
Format:	Article
Language:	English
Subjects:	692/308/153 692/699/67/1059 Adult Aged Antineoplastic Agents - therapeutic use B-cell lymphoma Cancer Cancer Research Cardiac arrhythmia Critical Care Medicine Drug dosages Drug therapy Drug therapy, Combination Enzymes Female Hematology Human health and pathology Humans Imidazoles - therapeutic use Indazoles - therapeutic use Intensive Internal Medicine Kinases Laboratories Letter Leukemia Life Sciences Lymphocytes B Lymphoma Lymphoma, B-Cell - drug therapy Lymphomas Male Medical research Medicine Medicine & Public Health Middle Aged Neutropenia Neutrophils Oncology Patients Protein Kinase Inhibitors - therapeutic use Purines - therapeutic use Pyrazines - therapeutic use Pyrimidines - therapeutic use Quinazolinones - therapeutic use Response rates Testing
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!